Publication | Open Access
Phosphodiesterase‐5 inhibition potentiates cerebrovascular reactivity in chronic traumatic brain injury
23
Citations
35
References
2018
Year
Single-dose sildenafil improves regional CVR deficits in chronic TBI patients. CVR and ΔCVR are potential predictive and pharmacodynamic biomarkers of PDE5 inhibitor therapy for TCVI. Sildenafil is a potential therapy for TCVI.
| Year | Citations | |
|---|---|---|
Page 1
Page 1